Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
06 April 2022 | Story Lacea Loader
NSFAS

The National Student Financial Aid Scheme (NSFAS) confirmed in a circular this week that monies will be paid to universities on 8 April 2022.

This will be the first payment that the University of the Free State (UFS) receives from NSFAS this year, as per the media statement by the Minister of Higher Education, Science and Innovation, Dr Blade Nzimande.

So far this year, the UFS management has made several concessions to students to alleviate their financial pressure while waiting for their NSFAS subsidies to be released.

This week, the university management – through active engagements and input from the Institutional Student Representative Council (ISRC) – agreed on the following process for book and meal allowances to be transferred to students’ bank accounts at the earliest possible opportunity:

  1. As in the past, the services of Fundi will be used to pay the allowances to students.
  2. Fundi will inform the recipients of monies received for them.
  3. After the banking details of students have been validated, monies are transferred to a student’s bank account. Fundi will inform students whose banking details are incorrect to rectify it on the Fundi website.
  4. Students who have not received payments before, will be requested to upload their banking details on the Fundi website, after which payment will be made.

It is anticipated that students whose bank accounts are with Standard Bank will receive notice of the payment of their allowance as soon as Friday, 8 April 2022.

Students banking with other banks will receive their payments subject to the inter-banking money transfer policies of the different banks, but not later than two business days after payment.

What students must do:

  1. Ensure that you upload the correct banking details.
  2. Upload your OWN banking details, not the banking details of friends or family.
  3. Ensure that your cellphone number is correct and active on PeopleSoft.
  4. Respond as quickly as possible to SMSes received from Fundi.

The university management would like to thank the majority of students for their patience during this difficult time while waiting for the NSFAS subsidies to be released.


Released by:
Lacea Loader (Director: Communication and Marketing)
Telephone: +27 51 401 2584 | +27 83 645 2454
Email: news@ufs.ac.za | loaderl@ufs.ac.za

News Archive

Otorhinolaryngology research hopes to decrease morbidity
2016-10-04

Description: Prof Riaz Seedat Tags: Prof Riaz Seedat

Prof Riaz Seedat, Head of the
Department of
Otorhinolaryngology at the UFS

Prof Riaz Seedat, Head of the Department of Otorhinolaryngology at the UFS is a world-renowned ear, nose and throat specialist and researcher. He is also a National Research Foundation C3 rated scientist.

He is conducting his research in ear, nose and throat (ENT) pathology in a developing world setting, particularly focusing on recurrent respiratory papillomatosis and other ENT conditions. “This condition is caused by human papillomavirus (HPV), infective conditions as well as allergic rhinitis,” said Prof Seedat.

Current research is aimed at further describing the epidemiology of recurrent respiratory papillomatosis, identification of the HPV variants responsible for causing the condition and markers of disease aggressiveness.

The research has led to various international partnerships such as the multicentre collaborative studies, “Genetic Susceptibility to Papilloma-induced Voice Disturbance” at the Centre for Genomic Sciences at the Allegheny-Singer Research Institute in Pittsburgh, United States, and the HPV6/11 Global Diversity Consortium at the University of Ljubljana in Slovenia.

Although most head and neck squamous cell carcinomas are caused by excessive tobacco and alcohol use, there is an increasing body of evidence to show that HPV causes a subset of head and neck squamous cell carcinomas. However, there are few studies on the role of HPV in head and neck neoplasms in developing countries.

“Through the research we have shown that recurrent respiratory papillomatosis, caused by HPV, is not as rare in South Africa as it is in developed countries and that patients usually present respiratory papillomatosis at an advanced stage when the condition is life-threatening,” said Prof Seedat.

“It is hoped that this research will help us to address the morbidity caused by ENT conditions common in developing countries,” said Prof Seedat.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept